| Literature DB >> 24967414 |
Enrico Giustiniano1, Massimo Meco2, Emanuela Morenghi3, Nadia Ruggieri1, Daniele Cosseta2, Silvia Cirri2, Orazio Difrancesco1, Paola Cosma Zito1, Yari Gollo1, Ferdinando Raimondi1.
Abstract
BACKGROUND: Patients who undergo high-risk surgery represent a large amount of post-operative ICU-admissions. These patients are at high risk of experiencing postoperative complications. Renal Resistive Index was found to be related with renal dysfunction, hypertension, and posttraumatic hemorrhagic shock, probably due to vasoconstriction. We explored whether Renal Resistive Index (RRI), measured after awakening from general anesthesia, could have any relationship with postoperative complications.Entities:
Mesh:
Year: 2014 PMID: 24967414 PMCID: PMC4055360 DOI: 10.1155/2014/917985
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Population characteristics.
| Age (years) | 61.7 ± 14.6 |
| BMI (Kg/m2 body surface area) | 25.4 ± 3.9 |
| ASA 3-4 ( | 102 (49.76%) |
| Smoking ( | 98 (47.80%) |
| Diabetes ( | 26 (12.68%) |
| Hypertension ( | 100 (48.78%) |
| COPD ( | 43 (20.98%) |
| Myocardiopathy ( | 94 (45.85%) |
| Serum creatinine (mg/dL) | 0.855 (0.44–2.0) |
| EF (%)* | 54.6 ± 8.4 |
| EDV (mL)* | 154 (55–180) |
| Urine albumin ( | 16 (7.80%) |
| Systolic arterial pressure (SAP) mmHg§ | 130 ± 19 |
| Diastolic arterial pressure (DAP) mmHg§ | 72 ± 12 |
| Mean arterial pressure (MAP) mmHg§ | 88 ± 15 |
| Heart Rate (bpm)§ | 75 ± 12 |
| Haematocrit (%) | 39.3 ± 5.4 |
*Only 96 patients underwent preoperative echocardiogram.
§Blood pressure and heart rate were recorded when patient arrived in operative room before any drug administration.
BMI: Body Mass Index; COPD: chronic obstructive pulmonary disease;
EF: ejection fraction; EDV: end-diastolic volume.
Risk factors and RRI > 0.7.
| Global population | Cardiothoracic population | |||||
|---|---|---|---|---|---|---|
| RRI < 0.7 | RRI > 0.7 |
| RRI < 0.7 | RRI > 0.7 |
| |
|
| 145 | 60 | 80 | 42 | ||
| Male ( | 101 (69.66%) | 38 (63.33%) | 0.378 | 57 (71.25%) | 29 (69.05%) | 0.800 |
| Age (years) | 60 ± 15 | 65 ± 13 | 0.045 | 60 ± 17 | 62 ± 13 | 0.388 |
| BMI (Kg/m2 body surface area) | 25.0 ± 3.9 | 26.4 ± 3.8 | 0.020 | 25.4 ± 4.1 | 26.7 ± 4.1 | 0.092 |
| ASA (3-4) | 65 (44.83%) | 37 (61.67%) | 0.028 | 48 (60.00%) | 28 (66.67%) | 0.470 |
| Smoking ( | 62 (42.76%) | 36 (60.00%) | 0.025 | 32 (40.00%) | 26 (61.90%) | 0.021 |
| Diabetes ( | 13 (8.97%) | 13 (27.67%) | 0.020 | 7 (8.75%) | 6 (14.29%) | 0.367 |
| Hypertension ( | 65 (44.83%) | 35 (58.33%) | 0.078 | 35 (43.75%) | 23 (57.76%) | 0.247 |
| COPD ( | 28 (19.31%) | 15 (25.00%) | 0.363 | 14 (17.50%) | 7 (16.67%) | 1.000 |
| Myocardiopathy ( | 61 (42.07%) | 33 (55.00%) | 0.091 | 41 (51.25%) | 23 (54.76%) | 0.712 |
| Serum creatinine (mg/dL) | 0.90 ± 0.38 | 1.08 ± 0.60 | 0.005 | 0.96 ± 0.49 | 1.17 ± 0.69 | 0.029 |
| EF (%) | 56 ± 8 | 53 ± 8 | 0.127 | 56 ± 9 | 53 ± 9 | 0.149 |
| EDV (mL) | 151 ± 21 | 133 ± 35 | 0.049 | 156 ± 9 | 138 ± 34 | 0.124 |
| Urine albumin ( | 8 (5.52%) | 8 (13.33%) | 0.083 | 5 (6.25%) | 5 (11.90%) | 0.310 |
| Systolic arterial pressure (SAP) mmHg | 130 ± 18 | 131 ± 21 | 0.813 | 129 ± 17 | 125 ± 17 | 0.274 |
| Diastolic arterial pressure (DAP) mmHg | 73 ± 11 | 71 ± 12 | 0.164 | 73 ± 10 | 69 ± 11 | 0.013 |
| Mean arterial pressure (MAP) mmHg | 89 ± 15 | 87 ± 17 | 0.204 | 87 ± 14 | 82 ± 13 | 0.058 |
| Heart Rate (bpm) | 76 ± 13 | 74 ± 12 | 0.518 | 76 ± 12 | 75 ± 11 | 0.744 |
| Haematocrit (%) | 39.9 ± 5.2 | 37.8 ± 5.7 | 0.030 | 40 ± 5 | 37 ± 6 | 0.014 |
| Surgical APGAR score (points) | 7 (1–10) | 7 (1–10) | 0.520 | 6 (1–10) | 6.5 (1–10) | 0.913 |
Blood pressure and heart rate were recorded when patients arrived in operative room but before any drug administration.
Surgical Apgar Score was calculated at the end of operation as it considers three items that have to be recorded after surgery completion.
Outcome results and RRI.
| Global population | Cardiothoracic population | |||||
|---|---|---|---|---|---|---|
| RRI < 0.7 | RRI > 0.7 |
| RRI < 0.7 | RRI > 0.7 |
| |
|
| 145 | 60 | 80 | 42 | ||
| Global complications | 27 (18.62%) | 19 (31.67%) | 0.042 | 14 (17.50%) | 15 (35.71%) | 0.042 |
| Suture leak | 2 (1.38%) | 2 (3.33%) | 0.582 | 0 | 0 | |
| Bleeding | 4 (2.76%) | 1 (1.67%) | 1.000 | 3 (3.75%) | 0 | 0.550 |
| ARDS | 1 (0.69%) | 3 (5.00%) | 0.076 | 1 (1.25%) | 3 (7.14%) | 0.117 |
| Pneumonia | 4 (2.76%) | 7 (11.67%) | 0.016 | 1 (1.25%) | 6 (14.29%) | 0.007 |
| Atelectasis | 3 (2.07%) | 3 (5.00%) | 0.361 | 1 (1.25%) | 3 (7.14%) | 0.117 |
| SIRS/Sepsis | 2 (1.38%) | 4 (6.67%) | 0.062 | 2 (2.50%) | 4 (9.52%) | 0.180 |
| Septic shock | 1 (0.69%) | 6 (10.00%) | 0.003 | 0 | 4 (9.52%) | 0.013 |
| ARF | 2 (1.38%) | 8 (13.33%) | 0.001 | 2 (2.50%) | 7 (16.67%) | 0.008 |
| Pulmonary embolism | 0 | 1 (1.67%) | 0.293 | 0 | 1 (2.38%) | 0.344 |
| Acute respiratory failure | 4 (2.76%) | 2 (3.33%) | 1.000 | 1 (1.25%) | 2 (4.76%) | 0.272 |
| Hepatic insufficiency | 1 (0.69%) | 0 | 1.000 | 0 | 0 | |
| Arrhythmia | 8 (5.52%) | 5 (8.33%) | 0.530 | 6 (7.50%) | 4 (9.52%) | 0.735 |
| ICU admission ( | 56 (38.62%) | 24 (40.00%) | 0.854 | 33 (41.25%) | 18 (42.86%) | 0.864 |
| ICU staying (days) | 1 (1–36) | 4 (1–38) | 0.001 | 3 (1–36) | 5.5 (2–38) | 0.006 |
| Mechanical ventilation ( | 53 (36.55%) | 19 (31.67%) | 0.505 | 33 (41.25%) | 17 (40.48%) | 0.934 |
| Mechanical ventilation (hours) | 12 (1–240) | 32 (6–300) | 0.004 | 12 (1–240) | 32 (6–300) | 0.001 |
| Length-of-stay (days) | 8 (1–37) | 8 (4–40) | 0.246 | 8 (1–22) | 8 (4–24) | 0.023 |
| Death ( | 2 (1.38%) | 3 (5.00%) | 0.151 | 1 (1.25%) | 2 (4.76%) | 0.272 |
Complications that did not occur are not reported. Some patients experienced more than 1 adverse event.
RRI classes and complications risk.
| Global population ( | Cardiothoracic subgroup ( | |
|---|---|---|
| RRI < 0.6 | 1 | 1 |
| RRI 0.60–0.65 | OR 1.34 (95% CI 0.39–4.75); | OR 1.02 (95% CI 0.17–6.06); |
| RRI 0.66–0.70 | OR 1.92 (95% CI 0.57–6.51); | OR 1.38 (95% CI 0.25–7.67); |
| RRI 0.71–0.75 | OR 2.93 (95% CI 0.79–10.9); | OR 3.38 (95% CI 0.59–19.4); |
| RRI > 0.75 | OR 3.10 (95% CI 0.85–11.3); | OR 2.75 (95% CI 0.47–16.0); |
When RRI > 0.7 OR triplicates, although it did not result to be statistically significant.
Figure 1The ROC curve.